Health Care·Pharmaceuticals·$547.6B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.19 | N/A | +1.71% |
management commentary, guidance changes, and full analysis available with Pro.
| +1.71% |
Tone: Cautiously Optimistic
Overall, management expressed a cautious optimism about future growth. They are committed to improving operational efficiency and investing in new products.
Management highlighted ongoing efforts to streamline operations.
They noted a focus on innovation and product development.
There was an emphasis on maintaining market leadership despite challenges.
This earnings report shows that Johnson & Johnson was able to exceed expectations on EPS, which indicates some level of operational efficiency. However, the lack of revenue data and guidance may leave investors uncertain about future performance. The stock reaction is not available, but the positive EPS surprise suggests some confidence in the company's financial health.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
TEXAS INSTRS INC
Jan 22, 2013